MedTrace Logo

Risk Factors for Shoulder Joint Motion Restriction

NCT05386641 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2022-05-31

No results posted yet for this study

Summary

In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.

Conditions

  • Breast Cancer Survivors

Interventions

OTHER

measurement of tissue stiffness (N/m)

Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain

OTHER

measurement of passive muscle tone (Hz)

muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain

OTHER

measurement of creep of tissue

creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain

OTHER

measurement of the range of shoulder joint motion

The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.

OTHER

measurement of skin temperature

measurements will be taken by the thermographic camera

OTHER

measurement of pain

Pain will be evaluated by visual analog scale (VAS)

OTHER

measurement of pain pressure threshold

Pain pressure threshold will be evaluated by a digital algometer

OTHER

measurement of grip strength

The grip strength of both hand will be evaluated by "hand-held" dynamometer.

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2023-08-15
Completion
2024-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05386641 on ClinicalTrials.gov